Journal Information
Vol. 28. Issue. 5.October 2008
Pages 475-573
Vol. 28. Issue. 5.October 2008
Pages 475-573
DOI:
Full text access
Disseminated histoplasmosis in a kidney transplant patient
Histoplasmosis diseminada en un paciente trasplantado renal.
Visits
3319
Hernán Trimarchia, Mariano Forrestera, Fernando Lombia, Vicente Campolo-Girarda, Pablo Youngb, Julio Bruetmanb, Jorge Finquelievichc, Roxana Jordanc, Ernesto Efronc, Iris Agoriod, Bárbara C. Finnb, Débora Pellegrinib
a Servicio de Nefrología, Hospital Británico de Buenos Aires, Buenos Aires, Buenos Aires, Argentina,
b Servicio de Clínica Médica, Hospital Británico de Buenos Aires, Buenos Aires, Buenos Aires, Argentina,
c Servicio de Infectología, Hospital Británico de Buenos Aires, Buenos Aires, Buenos Aires, Argentina,
d Servicio de Microbiología, Hospital Británico de Buenos Aires, Buenos Aires, Buenos Aires, Argentina,
This item has received
3319
Visits
Article information
Abstract
Full Text
Bibliography
Download PDF
Statistics
A los cuatro años de recibir un transplante renal vivo no relacionado por poliquistosis renal1, una paciente de 49 años comenzó con episodios de hipertermia. La inmunosupresión era metilprednisona 4 mg/día, micofenolato mofetil 2 g/día y tacrolimus 2 mg/día. Ingresó al hospital con la sospecha de quistes renales complicados y presentó nódulos subcutáneos que se biopsiaron y fueron consistentes con eritema nodoso. Se realizó una nefrectomía de un riñón nativo derecho pero persistió febril. Los cultivos fueron persistentemente negativos.
To the editor: Four years after receiving a kidney transplant from an unrelated living donor for polycystic kidney disease,1 a 49-year-old female patient started to experience episodes of hyperthermia. The immunosuppression regimen consisted of methylprednisone 4 mg/day, micophenolate mofetil 2 g/day, and tacrolimus 2 mg/day.
Full Text

To the editor: Four years after receiving a kidney  transplant from an unrelated living donor for polycystic kidney

disease,1 a  49-year-old  female  patient started  to experience episodes of hyperthermia. The immunosuppression

regimen consisted of methylprednisone 4  mg/day,  micophenolate  mofetil  2 g/day,  and  tacrolimus  2  mg/day.  She was  admitted  to  hospital  for  suspicion of  complicated  renal  cysts  and  was found  subcutaneous  nodules  that were biopsied and seen to be consistent with erythema  nodosum.  Nephrectomy  of the right native kidney was performed, but  fever persisted. Cultures were persistently  negative.  Patient  developed massive  ascites.  Magnetic  resonance imaging  showed  ascites  and  a  complicated liver cyst, that was marsupialized, and  two  liters of  ascites were drained. Peritoneum  was  normal  upon  inspection. After 22 days of  incubation, subcutaneous  nodules  developed  colonies of Histoplasma capsulatum. Fever persisted  despite  itraconazole  administration, and amphotericin B was therefore added. Subsequent blood, urine, and ascites  fluid  cultures  were  positive  for Histoplasma capsulatum. Fever and ascites resolved 29 days after hospital admission,  and  patient  was  discharged home. Two weeks later, fever and subcutaneous nodules in the arms recurred. Severe  pericardial  effusion with  ultrasonographic  signs  of  tamponade  was diagnosed. The patient died during  the procedure.



While early fungal infections are less commonly  reported  in  kidney  transplant  patients  than  in  other  transplant

patients,  their  mortality  is  high.2 These patients have a high risk of suffering  late  opportunistic  infections,

particularly  by  Listeria, Nocardia, Mycobacteria,  or  fungi,  associated  to use  of  venous  catheters,  antibiotics,

corticosteroids,  surgical procedures, and diabetes mellitus.



Approximately after 6 months since transplant, incidence of opportunistic fungal infections decreases, but an increase occurs in the incidence of systemic endemic fungal disease, of which histoplasmosis and coccidioidomycosis are the most significant. Histoplasmosis is  the most  common  endemic mycosis in  immunosuppressed  patients  in  Argentina,3,5 with  an  incidence  rate up  to 40%  in humid,  temperate areas.  In our country, the most common clinical presentations  in healthy  individuals  include the pulmonary variant and the chronic  disseminated  variant  associated  to mucocutaneous  lesions,  adenomegalies, hepatomegaly, and splenomegaly.6 In normal subjects, primary infection is  usually  asymptomatic  in more  than 90%  of  cases.  In  a  lower  proportion, clinical  signs  include  pericarditis, mediastinitis,  erythema  nodosum,  or  retinitis.7



Ascites is a complication of systemic histoplasmosis  not  previously  reported in the 48 cases of histoplasmosis in kidney  transplant.  It  should  be  noted  that surgeons  did  not  take  peritoneal  biopsies during abdominal  laparoscopy because  of  the  normal  characteristics  of the serosa. This could be due to the abnormal inflammation patterns in immunosuppressed  patients.  We  think  random  peritoneal  biopsies  should  be

performed  despite  absence  of  gross structural  changes  when  the  cause  of ascites has not been diagnosed.8



Patients  transplanted  solid  organs have an  increased  risk of suffering opportunistic  infections.  Systemic  histoplasmosis  is  a  rare  and  serious  condition  that  should  be  considered  as  a long-term  complication  in  transplant patients.

Bibliography
[1]
Trimarchi H, Freixas E, Rabinovich O, Schropp J, Pereyra H, Bullorsky E. Cyclosporin-associated thrombotic microangiopathy during daclizumab induction. A suggested therapeutic approach. Nephron 87: 361-4, 2001. [Pubmed]
[2]
Jha V, Krishna S, Varma N, et al. Disseminated histoplasmosis 19 years after renal transplantation. Clin Nephrol 51: 373-8, 1999. [Pubmed]
[3]
Dictar M, Maiolo E, Alexander B, Jacob N, Veron MT. Mycosis in the transplant patient. Medical Mycology 38 Suppl I: 251-258, 2000.
[4]
Negroni R, Robles AM, Arechavala A, Bianchi M, Helou S. Histoplasmosis relacionada al SIDA, su estado actual en la Argentina. Prensa Médica Argentina 84: 696-700, 1997.
[5]
Corti ME, Cendoya CA, Soto I, et al. Disseminated Histoplasmosis and AIDS: Clinical Aspects and Diagnostic Methods for Early Detection. AIDS Patient Care and STDs 14: 149-54, 2000.
[6]
Rubisntein P, Negroni R. Histoplasmosis. Cap 6. Micosis broncopulmonares del adulto y del niño. Ed. Beta, Buenos Aires. 2ºEdición 1981.
[7]
Wheat J, Kauffman CA. Histoplasmosis. Infect Dis Clin N Am 17: 1-19, 2003.
[8]
Wheat J. Histoplasmosis. Experience during outbreaks in Indianapolis and review of the literature. Medicine (Baltimore) 76: 339-54, 1997.
Idiomas
Nefrología (English Edition)

Subscribe to our newsletter

Article options
Tools
es en

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

es en
Política de cookies Cookies policy
Utilizamos cookies propias y de terceros para mejorar nuestros servicios y mostrarle publicidad relacionada con sus preferencias mediante el análisis de sus hábitos de navegación. Si continua navegando, consideramos que acepta su uso. Puede cambiar la configuración u obtener más información aquí. To improve our services and products, we use "cookies" (own or third parties authorized) to show advertising related to client preferences through the analyses of navigation customer behavior. Continuing navigation will be considered as acceptance of this use. You can change the settings or obtain more information by clicking here.